LFST Stock Down -16% after 8-Day Loss Streak
LifeStance Health (LFST) stock hit day 8 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -16% return. The company has lost about $294 Mil in valuation over the last 8 days, with its current market capitalization being $1.9 Bil. The stock remains 34.5% below its value at the end of 2024. This compares with year-to-date returns of 1.5% for the S&P 500 and -0.8% for the Trefis High Quality Portfolio.
Comparing LFST Stock Returns With The S&P 500
The following table summarizes the return for LFST stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | LFST | S&P 500 |
| 1D | -2.0% | -0.2% |
| 8D (Current Streak) | -17.9% | -0.6% |
| 1M (21D) | -17.2% | 0.5% |
| 3M (63D) | -29.2% | 5.4% |
| YTD 2025 | -34.5% | 1.5% |
| 2024 | -5.9% | 23.3% |
| 2023 | 58.5% | 24.2% |
| 2022 | -48.1% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 21 S&P constituents with 3 days or more of consecutive gains and 92 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
| 3D | 8 | 75 |
| 4D | 11 | 4 |
| 5D | 0 | 10 |
| 6D | 1 | 0 |
| 7D or more | 1 | 3 |
| Total >=3 D | 21 | 92 |
Key Financials for LifeStance Health (LFST)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
| Revenues | $1.1 Bil | $1.3 Bil |
| Operating Income | $-189.1 Mil | $-31.6 Mil |
| Net Income | $-186.3 Mil | $-57.4 Mil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
| Revenues | $325.5 Mil | $333.0 Mil |
| Operating Income | $1.1 Mil | $1.6 Mil |
| Net Income | $-7.1 Mil | $0.7 Mil |
The losing streak LFST stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.